Trials / Not Yet Recruiting
Not Yet RecruitingNCT07422142
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of Gastrodin Injection in Healthy Chinese Subjects
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 54 (estimated)
- Sponsor
- Kunming Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This is a single-center, double-blind study to evaluate the safety, tolerability, pharmacokinetics of Gastrodin Injection in healthy Subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | gastrodin injection；placebo | Single-dose intravenous administration of gastrodin injection or placebo |
| DRUG | gastrodin injection；placebo | Multiple-dose intravenous administration of gastrodin injection or placebo |
Timeline
- Start date
- 2026-03-01
- Primary completion
- 2026-09-30
- Completion
- 2026-09-30
- First posted
- 2026-02-19
- Last updated
- 2026-02-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07422142. Inclusion in this directory is not an endorsement.